Evidence map›Paper›PMID 41847351›Full record

ArticleJournal of the American College of Emergency Physicians open2026

Assessment of a County-Wide, Pan-First Responder Take-Home Naloxone Program in Denver, Colorado.

Joshua Jacoves, Alexandra Mannerings, Donald Stader, Mario Andres Camacho, James Neuenschwander, Ansley Mason, Katelynn Petrasic, Scott G Weiner

Abstract read
In one paragraph

Article in Journal of the American College of Emergency Physicians open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joshua JacovesThe Naloxone Project, Denver, Colorado, USA.
Alexandra ManneringsThe Naloxone Project, Denver, Colorado, USA.
Donald StaderThe Naloxone Project, Denver, Colorado, USA.
Mario Andres CamachoDepartment of Emergency Medicine, Denver Health Medical Center, University of Colorado School of Medicine, Denver, Colorado, USA.
James NeuenschwanderDepartment of Emergency Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Ansley MasonThe Naloxone Project, Denver, Colorado, USA.
Katelynn PetrasicThe Naloxone Project, Denver, Colorado, USA.
Scott G WeinerDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate the feasibility and geospatial distribution of a county-wide pan-first responder leave-behind naloxone program implemented across emergency medical services (EMS), police, fire, and a community response mobile crisis unit. Methods: We conducted a retrospective analysis of leave-behind naloxone kits distributed in Denver, Colorado, from April 26, 2024, through April 25, 2025. Trained first responders ( Results: Over the 12-month period, there were 1020 interactions during which responders distributed 2438 naloxone kits. Paramedics accounted for 1407 kits (57.7%), the mobile crisis unit for 642 (26.3%), police for 336 (13.8%), and fire for 53 (2.2%). In many interactions, the kit recipient declined transport, particularly in the mobile crisis unit and EMS cohorts. Geospatial analysis identified 24 hotspots, of which 23 were within feasible walking distance of bus or light-rail stops. These findings suggest that leave-behind naloxone distributions cluster around transportation hubs in Denver. Conclusion: A pan-first-responder leave-behind naloxone program is feasible at the county level, with most kits distributed by paramedics and a mobile crisis unit program. Hotspot analysis highlighted transit-adjacent clusters, informing potential sites for prestationed naloxone. Cross-agency collaboration combined with geospatial targeting may rapidly saturate high-risk settings with naloxone.

Identifiers

PMID41847351
PMCPMC12990331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.